Metraipolis › archive › dc_a5b645449503

Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis — Europe PMC PMID:41595737

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41595737
DOI
10.3390/biomedicines14010203
License (as archived)
solo-consultazione
Archived
2026-11-06T17:46:27.489Z
SHA-256 of the archived text
fd2ac888221249e8ff9472ca7c4e362e148e517f24be49555d3361384f757a9c
Stable URL of this page
https://metraipolis.com/documento/dc_a5b645449503

How to cite

Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis — Europe PMC PMID:41595737 — Europe PMC (en), https://europepmc.org/article/MED/41595737 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5b645449503 (Metraipolis archive dc_a5b645449503, sha256 fd2ac888221249e8ff9472ca7c4e362e148e517f24be49555d3361384f757a9c)
BibTeX
@misc{dca5b645449503,
  title = {Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis — Europe PMC PMID:41595737},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41595737},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5b645449503; sha256 fd2ac888221249e8ff9472ca7c4e362e148e517f24be49555d3361384f757a9c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41595737. Agents can read the archived copy with the MCP tool read_document.